Berkeley News company blog

FDA approves first test of CRISPR for genetic defect causing sickle cell disease

UC scientists and physicians hope to permanently cure patients of sickle cell disease by using CRISPR-Cas9 to replace a defective gene with the normal version
Points
440
HN comments
132
Submissions
1
Cited by
0 commenters

Science & Space2021

On Hacker News

SubmittedTitle on HNPointsComments
Apr 7, 2021FDA approves first test of CRISPR for genetic defect causing sickle cell disease by zuhayeer440132

More from Berkeley News

All 23 posts →

Related posts from the same era